Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
5 trials
Recent
Start date
Enrollment
Phase 3
×
Has results
×
lanreotide
×
Clear all
Filters
3
NCT00353496
2025-03-05
CLARINET
Ipsen
Phase 3
Completed
264 enrolled
17 charts
NCT00774930
2022-10-14
ELECT
Ipsen
Phase 3
Completed
115 enrolled
17 charts
NCT00842348
2022-10-12
NET729
Ipsen
Phase 3
Completed
89 enrolled
9 charts
NCT02683941
2022-07-06
SPINET
Ipsen
Phase 3
Terminated
77 enrolled
20 charts
NCT01313273
2019-11-22
POSEIDON
Ipsen
Phase 3
Terminated
3 enrolled
4 charts